Physician profile
Samuel C Lee
NPI 1770508376
$4,215.97
in general payments reported to CMS, 2019-2025
24 companies · $49.87 in 2025
The $49.87 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2020: $845 · 2021: $1,800 · 2022: $652 · 2023: $185 · 2024: $248 · 2025: $49.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $822.74 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $469.01 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $438.60 | 2020-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $408.40 | 2019-2023 | Farxiga |
| Lilly USA, LLC | $316.29 | 2019-2023 | Mounjaro, Jardiance |
| Abbvie INC. | $281.04 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $197.53 | 2019-2022 | |
| Amarin Pharma, INC. | $177.38 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $171.14 | 2020-2022 | |
| Astellas Pharma US INC | $166.51 | 2021-2025 | Xtandi |
| Nalu Medical, INC. | $145.00 | 2024 | Nalu Neurostimulation System |
| Exact Sciences Corporation | $121.19 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $116.25 | 2020-2021 | |
| Antares Pharma, INC. | $99.40 | 2021-2022 | |
| Horizon Therapeutics Plc | $53.14 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $44.79 | 2020 | |
| Dexcom, INC. | $36.48 | 2022 | |
| Novartis Pharmaceuticals Corporation | $29.51 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.10 | 2021-2022 | |
| Boston Scientific Corporation | $25.31 | 2023 | Wavewriter Alpha Prime 16 |
| Allergan, INC. | $24.57 | 2020 | |
| Abbott Laboratories | $19.29 | 2023 | Freestyle Libre 2 |
| Philips North America LLC | $13.97 | 2022 | |
| Nabriva Therapeutics, Plc | $11.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.